Intravascular lymphoma: a role for single-agent rituximab

References

• Harris N L, Jaffe E S, Diebold J, Flandrin G, Muller-Hermelink H K, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835–3849
   PubMed Web of Science ®Google Scholar
• Pfleger L, Tappeiner J. On the recognition of systematized endotheliomatosis of the cutaneous blood vessels (reticuloendotheliosis). Hautarzt 1959; 10: 359–363
   PubMedGoogle Scholar
• Wach M, Dmoszynska A, Skomra D, Wasik-Szczepanek E, Szumilo J. Intravascular B-cell lymphoma in a 38-year-old woman: a case report. Ann Hematol 2001; 80: 224–227
   PubMed Web of Science ®Google Scholar
• Smadja D, Mas J L, Fallet-Bianco C, Meyniard O, Sicard D, de Recondo J, Rondot P. Intravascular lymphomatosis (neoplastic angioendotheliosis) of the central nervous system: case report and literature review. J Neurooncol 1991; 11: 171–180
   PubMed Web of Science ®Google Scholar
• Sheibani K, Battifora H, Winberg C D, Burke J S, Ben-Ezra J, Ellinger J M, et al. Further evidence that ‘malignant angioendotheliomatosis’ is an angiotropic large-cell lymphoma. N Engl J Med 1986; 314: 943–948
   PubMed Web of Science ®Google Scholar
• Stroup R M, Sheibani K, Moncada A, Purdy L J, Battifora H. Angiotropic (intravascular) large cell lymphoma. A clinicopathologic study of seven cases with unique clinical presentations. Cancer 1990; 66: 1781–1788
   PubMed Web of Science ®Google Scholar
• DiGiuseppe J A, Nelson W G, Seifter E J, Boitnott J K, Mann R B. Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy. J Clin Oncol 1994; 12: 2573–2579
   PubMed Web of Science ®Google Scholar
• Wick M R, Mills S E, Scheithauer B W, Cooper P H, Davitz M A, Parkinson K. Reassessment of malignant ‘angioendotheliomatosis’. Evidence in favor of its reclassification as ‘intravascular lymphomatosis’. Am J Surg Pathol 1986; 10: 112–123
   PubMed Web of Science ®Google Scholar
• Sepp N, Schuler G, Romani N, Geissler D, Gattringer C, Burg G, et al. ‘Intravascular lymphomatosis’ (angioendotheliomatosis): evidence for a T-cell origin in two cases. Hum Pathol 1990; 21: 1051–1058
   PubMed Web of Science ®Google Scholar
• Domizio P, Hall P A, Cotter F, Amiel S, Tucker J, Besser G M, Levison D A. Angiotropic large cell lymphoma (ALCL): morphological, immunohistochemical and genotypic studies with analysis of previous reports. Hematol Oncol 1989; 7: 195–206
   PubMed Web of Science ®Google Scholar
• Wu H, Said J W, Ames E D, Chen C, McWhorter V, Chen P, et al. First reported cases of intravascular large cell lymphoma of the NK cell type: clinical, histologic, immunophenotypic, and molecular features. Am J Clin Pathol 2005; 123: 1–9
   Web of Science ®Google Scholar
• Ponzoni M, Arrigoni G, Gould V E, Del Curto B, Maggioni M, Scapinello A, et al. Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol 2000; 31: 220–226
   PubMed Web of Science ®Google Scholar
• Ferry J A, Harris N L, Picker L J, Weinberg D S, Rosales R K, Tapia J, Richardson E P, Jr. Intravascular lymphomatosis (malignant angioendotheliomatosis). A B-cell neoplasm expressing surface homing receptors. Mod Pathol 1988; 1: 444–452
   PubMed Web of Science ®Google Scholar
• Glass J, Hochberg F H, Miller D C. Intravascular lymphomatosis. A systemic disease with neurologic manifestations. Cancer 1993; 71: 3156–3164
   PubMed Web of Science ®Google Scholar
• Baehring J M, Longtine J, Hochberg F H. A new approach to the diagnosis and treatment of intravascular lymphoma. J Neurooncol 2003; 61: 237–248
   PubMed Web of Science ®Google Scholar
• Calamia K T, Miller A, Shuster E A, Perniciaro C, Menke D M. Intravascular lymphomatosis. A report of 10 patients with central nervous system involvement and a review of the disease process. Adv Exp Med Biol 1999; 455: 249–265
   PubMed Web of Science ®Google Scholar
• Wick M R, Mills S E. Intravascular lymphomatosis: clinicopathologic features and differential diagnosis. Semin Diagn Pathol 1991; 8: 91–101
   PubMed Web of Science ®Google Scholar
• Ferreri A J, Campo E, Seymour J F, Willemze R, Ilariucci F, Ambrosetti A, et al. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’. Br J Haematol 2004; 127: 173–183
   PubMed Web of Science ®Google Scholar
• Gill S, Melosky B, Haley L, Chan Yan C. Use of random skin biopsy to diagnose intravascular lymphoma presenting as fever of unknown origin. Am J Med 2003; 114: 56–58
   PubMed Web of Science ®Google Scholar
• Kraus M D, Jones D, Bartlett N L. Intravascular lymphoma associated with endocrine dysfunction: a report of four cases and a review of the literature. Am J Med 1999; 107: 169–176
   PubMed Web of Science ®Google Scholar
• Demirer T, Dail D H, Aboulafia D M. Four varied cases of intravascular lymphomatosis and a literature review. Cancer 1994; 73: 1738–1745
   PubMed Web of Science ®Google Scholar
• Dubas F, Saint-Andre J P, Pouplard-Barthelaix A, Delestre F, Emile J. Intravascular malignant lymphomatosis (so-called malignant angioendotheliomatosis): a case confined to the lumbosacral spinal cord and nerve roots. Clin Neuropathol 1990; 9: 115–120
   PubMed Web of Science ®Google Scholar
• Tranchida P, Bayerl M, Voelpel M J, Palutke M. Testicular ischemia due to intravascular large B-cell lymphoma: a novel presentation in an immunosuppressed individual. Int J Surg Pathol 2003; 11: 319–324
   PubMed Web of Science ®Google Scholar
• Weichert G, Martinka M, Rivers J K. Intravascular lymphoma presenting as telangectasias: response to rituximab and combination chemotherapy. J Cutan Med Surg 2003; 7: 460–463
   PubMed Web of Science ®Google Scholar
• Takacs I, Eros N, Bene I, Bozso F, Tordai L, Karolyi Z, et al. Successful treatment of relapse of an intravascular B-cell lymphoma with rituximab-CHOP polychemotherapy. Ann Hematol 2004; 83: 608–610
   PubMed Web of Science ®Google Scholar
• Davis T S. Intravascular lymphoma presenting with cauda equina syndrome: treated with CHOP and rituxan. Leuk Lymphoma 2003; 44: 887–888
   PubMed Web of Science ®Google Scholar
• Han K, Haley J C, Carlson K, Pinter-Brown L, Soriano T. Regression of cutaneous intravascular lymphoma with rituximab. Cutis 2003; 72: 137–140
   PubMed Web of Science ®Google Scholar
• Alfaro J, Espinoza A, Manriquez M, Moyano L, Gonzalez N, Larrondo M, Figueroa G. Intravascular lymphoma treated with anti CD20 monoclonal antibodies. Report of one case. Rev Med Chil 2004; 132: 1403–1406
   PubMed Web of Science ®Google Scholar